The Da Nang-based Danapha Pharmaceutical JSC on Saturday morning broke ground on its new pharmaceutical manufacturing plant, and high-tech research and development centre, in the Da Nang Hi-tech Park.

An architectural design for the ‘pharmaceutical manufacturing plant and high-tech research and development centre’ project. Photo: T.XUAN

Speaking at the groundbreaking ceremony, Da Nang People’s Committee Vice Chairman Tran Phuoc Son highlighted the great significance of the developments in the context of the whole country ramping up efforts to ensure the proactive supply of vaccines and medicines for its fight against COVID-19.

The city leader hoped that, once fully operational, the developments will significantly contribute to helping the city effectively implement the National Government's scientific and technological development orientations, as well as to driving the city’s economic growth and improving the living standards of locals. In addition, the project will help Da Nang realise its target of becoming a reputable medicine exporter in the region and in the world, thereby increasingly improving the position of Viet Nam's pharmaceutical industry.

Vice Chairman Son asked the project’s investor and construction units to mobilise maximum resources to ensure the on-schedule progress of the project.

The pharmaceutical manufacturing plant and high-tech research and development centre, with a designed capacity of about 1.5 billion doses/ year, will be built on an area of 3ha in the Da Nang Hi-Tech Park in Hoa Vang District’s Hoa Lien Commune. Developed by the Danapha Pharmaceutical JSC, the VND900 billion project will be divided into two phases.

The 1^st stage of the project, which will feature a factory, production lines with different dosage forms and a modern research and development centre meeting European GMP standards, is expected to be put into operation in 2023.

Reporting by D.ANH, T.XUAN - Translating by M.DUNG